Home › Sjögren's Disease › Texas › Arlington
Sjögren's Disease clinical trials in Arlington, TX
4 studies for Sjögren's Disease are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Precision Comprehensive Clinical Research Solutions, Euless · 7 mi away
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Precision Comprehensive Clinical Research Solutions, Euless · 7 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Arlington, Arlington
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Precision Comprehensive Clinical Research Solutions, Colleyville · 10 mi away
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Clearwater, FL4 studies
- Cicero, IL4 studies
- Charlotte, NC4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
- Orlando, FL3 studies
Other studies in Arlington
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer4 studies
- Non-Muscle Invasive Bladder Cancer4 studies
- Chronic Kidney Disease4 studies
- High Blood Pressure4 studies
- Rheumatoid Arthritis4 studies
- Lupus3 studies
- Breast Cancer3 studies
- Ulcerative Colitis3 studies
- Bladder Cancer3 studies
- Cirrhosis3 studies
- Pneumococcal Infections3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.